{"id":"placebo-comparator-no-ceftriaxone","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL6067656","moleculeType":"Small molecule","molecularWeight":"1323.22"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"In this Phase 3 trial design, the placebo comparator group receives no ceftriaxone (a third-generation cephalosporin antibiotic) to establish a baseline for efficacy and safety comparison against the active treatment arm. This allows researchers to measure the true clinical benefit of ceftriaxone administration in the studied patient population.","oneSentence":"This is a placebo control arm with no active antibiotic intervention, used as a comparator in a clinical trial.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:51:18.428Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT06819592","phase":"PHASE3","title":"PRophylaxis Against Early VENTilator-associated Infections in Acute Brain Injury","status":"RECRUITING","sponsor":"The George Institute","startDate":"2025-10-30","conditions":"All-cause Mortality, Quality of Life, Disability, Intellectual","enrollment":3300},{"nctId":"NCT03012360","phase":"PHASE4","title":"Antimicrobial Treatment in Patients With Ventilator-associated Tracheobronchitis","status":"TERMINATED","sponsor":"University Hospital, Lille","startDate":"2018-02-08","conditions":"Mechanical Ventilation Complication, Critical Illness","enrollment":103},{"nctId":"NCT04999592","phase":"PHASE2","title":"Ceftriaxone to PRevent pneumOnia and inflammatTion aftEr Cardiac arresT (PROTECT)","status":"TERMINATED","sponsor":"David J. Gagnon","startDate":"2021-08-20","conditions":"Out-Of-Hospital Cardiac Arrest, Pneumonia","enrollment":53},{"nctId":"NCT03294395","phase":"PHASE3","title":"New AntiBiotic Treatment Options for Uncomplicated Anogenital GOnorrhoea","status":"COMPLETED","sponsor":"Public Health Service of Amsterdam","startDate":"2017-09-18","conditions":"Gonorrhea","enrollment":346}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo comparator - no ceftriaxone","genericName":"Placebo comparator - no ceftriaxone","companyName":"The George Institute","companyId":"the-george-institute","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}